HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.

AbstractBACKGROUND:
In nonhypertensive individuals, lower levels of 25-hydroxyvitamin D (25[OH]D) have been associated with an increased risk of hypertension, and vitamin D deficiency has been associated with endothelial dysfunction in such individuals. However, the effect of vitamin D supplementation on endothelial dysfunction in nonhypertensive individuals has not been examined in a rigorous fashion.
METHODS:
In this randomized, double-blind, placebo-controlled trial of nonhypertensive, nondiabetic overweight, or obese individuals with vitamin D deficiency (body mass index ≥25 and 25[OH]D ≤ 20 ng/ml), we assigned subjects to receive either ergocalciferol (50,000 units) or matching placebo, once a week for 8 weeks. Our primary outcome was endothelial-dependent vasodilation (EDV) measured by brachial artery ultrasound at baseline and 8 weeks postrandomization.
RESULTS:
By the end of the trial, 46 and 47 participants were allocated to receive ergocalciferol and placebo, respectively. Mean 25(OH)D levels increased from 14.9 to 30.3 in the vitamin D group and 14.4 to 17.4 in the placebo. EDV did not change significantly with either vitamin D repletion (from 6.3 ± 3.6% at baseline to 6.1 ± 4.6% at 8 weeks; P value = 0.78) or placebo (7.9 ± 4.7% to 6.8 ± 4.7%; P = 0.17). The treatment effect P value (comparing the 8-week change with ergocalciferol to the change with placebo) was 0.35.
CONCLUSIONS:
In this randomized, double-blind, placebo-controlled trial, there was no improvement in endothelial function (measured as EDV) after repletion of vitamin D in overweight/obese nonhypertensive individuals.
AuthorsLea Borgi, Ciaran McMullan, Ann Wohlhueter, Gary C Curhan, Naomi D Fisher, John P Forman
JournalAmerican journal of hypertension (Am J Hypertens) Vol. 30 Issue 2 Pg. 124-129 (Feb 2017) ISSN: 1941-7225 [Electronic] United States
PMID28077419 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© American Journal of Hypertension, Ltd 2016. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Vitamins
  • Vitamin D
  • 25-hydroxyvitamin D
Topics
  • Administration, Oral
  • Adult
  • Brachial Artery (diagnostic imaging, drug effects, physiopathology)
  • Dietary Supplements
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Endothelium, Vascular (drug effects, physiopathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Radioimmunoassay
  • Time Factors
  • Treatment Outcome
  • Ultrasonography
  • Vasodilation (drug effects, physiology)
  • Vitamin D (administration & dosage, analogs & derivatives, blood)
  • Vitamin D Deficiency (blood, drug therapy, physiopathology)
  • Vitamins (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: